Aclaris Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ACRS Nasdaq 8731 https://www.aclaristx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aclaris Therapeutics Inc

Aclaris Therapeutics Expands Leadership Team - Jun 27th, 2022 11:00 am
Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year? - Jun 22nd, 2022 1:40 pm
Aclaris (ACRS) Moves 5.5% Higher: Will This Strength Last? - Jun 20th, 2022 12:20 pm
Does Aclaris (ACRS) Have the Potential to Rally 141% as Wall Street Analysts Expect? - Jun 13th, 2022 1:55 pm
Has Aclaris Therapeutics (ACRS) Outpaced Other Medical Stocks This Year? - Jun 6th, 2022 1:40 pm
Aclaris Therapeutics to Participate in the Jefferies Healthcare Conference - Jun 1st, 2022 8:01 pm
Wall Street Analysts Believe Aclaris (ACRS) Could Rally 179%: Here's is How to Trade - May 27th, 2022 1:55 pm
KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M - May 17th, 2022 3:53 pm
Aclaris Therapeutics to Participate in the H.C. Wainwright Global Investment Conference - May 16th, 2022 11:00 am
Aclaris Therapeutics (ACRS) Reports Q1 Loss, Misses Revenue Estimates - May 10th, 2022 12:15 pm
Aclaris Therapeutics Reports First Quarter 2022 Financial Results and Provides a Corporate Update - May 10th, 2022 11:00 am
Lannett (LCI) Reports Q3 Loss, Lags Revenue Estimates - May 4th, 2022 11:35 pm
Aclaris Therapeutics to Participate in the LifeSci Partners Immunology & Inflammation Symposium - May 3rd, 2022 11:00 am
We're Hopeful That Aclaris Therapeutics (NASDAQ:ACRS) Will Use Its Cash Wisely - May 2nd, 2022 10:10 am
FEC Resources Reports on SC 72 Force Majeure Declaration - Apr 13th, 2022 4:17 am
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Misses Revenue Estimates - Feb 24th, 2022 1:55 pm
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update - Feb 24th, 2022 12:00 pm
Those who invested in Aclaris Therapeutics (NASDAQ:ACRS) three years ago are up 97% - Feb 21st, 2022 9:34 am
Earnings Preview: Aclaris Therapeutics (ACRS) Q4 Earnings Expected to Decline - Feb 17th, 2022 8:03 pm
Did Hedge Funds Catch A Break With Aclaris Therapeutics, Inc. (ACRS)? - Feb 6th, 2022 9:33 pm